Association of tumor necrosis factor-a gene promoter polymorphism at sites-308 and-238 with non-alcoholic fatty liver disease: A meta-analysis

被引:48
作者
Wang, Ji-kai [1 ]
Feng, Zhe-wei [1 ]
Li, Ying-chun [1 ]
Li, Qing-yan [1 ]
Tao, Xing-yong [1 ]
机构
[1] Anhui Med Univ, Sch Publ Hlth, Dept Gen Practice, Hefei 230032, Anhui, Peoples R China
关键词
non-alcoholic fatty liver disease; meta-analysis; polymorphism; tumor necrosis factor-alpha; TNF-ALPHA GENE; INDUCED INSULIN-RESISTANCE; CHINESE PATIENTS; NASH; PATHOLOGY; MICE;
D O I
10.1111/j.1440-1746.2011.06978.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background and Aim: Environmental and genetic factors play a role in the pathogenesis and natural history of non-alcoholic fatty liver disease (NAFLD). The objective of this study was to quantitatively evaluate the association between tumor necrosis factor (TNF)-a gene promoter polymorphism at sites -308 and -238 and NAFLD susceptibility. Methods: We performed an extensive search of relevant studies and made a meta-analysis, including eight studies with 837 NAFLD cases and 990 controls in the association between TNF-alpha -308 polymorphism and NAFLD; and seven studies with 771 cases and 787 controls in TNF-alpha -238 polymorphism. Results: The combined results showed that there was a significant difference in INF-a238 genotype distribution between NAFLD and control based on all studies (GA/AA vs GC 'odds ratio = 2.06, 95% confidence interval = 1.58-2.69, P < 0.000 01]). However, the combined results based on all studies showed there was no evidence of association of TNF-alpha-308 genotype distribution between NAFLD cases and controls (GA/AA vs GC [odds ratio = 1.08, 95% confidence interval = 0.82-1.42, P = 0.60]). When stratifying for race, the significant results did not change materially compared with whole populations. Conclusion: This meta-analysis suggested that TNF-a gene promoter polymorphism at position -238 but not -308 might be a risk factor for NARA).
引用
收藏
页码:670 / 676
页数:7
相关论文
共 35 条
[1]
Molecular genetics of NASH: The role of polymorphisms [J].
Alisi, Anna ;
Nobili, Valerio .
JOURNAL OF HEPATOLOGY, 2007, 47 (06) :868-869
[2]
Aller R, 2010, ANN HEPATOL, V9, P439
[3]
Non-alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases [J].
Angelico, F ;
Del Ben, M ;
Conti, R ;
Francioso, S ;
Feole, K ;
Maccioni, D ;
Antonini, TM ;
Alessandri, C .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (05) :588-594
[4]
The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones [J].
Arner, P .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (03) :137-145
[5]
Functional analysis of linker-scan mutants spanning the-376-308,-244, and-238 polymorphic sites of the TNF-α promoter [J].
Bayley, JP ;
de Rooij, H ;
van den Elsen, PJ ;
Huizinga, TWJ ;
Verweij, CL .
CYTOKINE, 2001, 14 (06) :316-323
[6]
Pathology of nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (04) :195-203
[7]
Genes and Nonalcoholic Fatty Liver Disease [J].
de Alwis, Nimantha Mark Wilfred ;
Day, Christopher Paul .
CURRENT DIABETES REPORTS, 2008, 8 (02) :156-163
[8]
Endo M, 2007, EXP BIOL MED, V232, P614
[9]
Tumor necrosis factor microsatellite polymorphisms in Italian glioblastoma patients [J].
Frigerio, S ;
Ciusani, E ;
Pozzi, A ;
Silvani, A ;
Salmaggi, A ;
Boiardi, A .
CANCER GENETICS AND CYTOGENETICS, 1999, 109 (02) :172-174
[10]
New insights in the pathogenesis of non-alcoholic fatty liver disease [J].
Gaemers, Ingrid C. ;
Groen, Albert K. .
CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (03) :268-273